OPKO Health, Inc. (NASDAQ:OPK – Get Rating) Vice Chairman Elias A. Zerhouni bought 89,600 shares of the business’s stock in a transaction dated Tuesday, May 10th. The shares were bought at an average cost of $2.79 per share, for a total transaction of $249,984.00. Following the transaction, the insider now owns 89,600 shares in the company, valued at approximately $249,984. The acquisition was disclosed in a document filed with the SEC, which can be accessed through the SEC website.

AstraZeneca (LON:AZN – Get Rating)’s stock had its “overweight” rating reissued by equities research analysts at Morgan Stanley in a note issued to investors on Wednesday, Marketbeat.com reports.